- Home
- TSBX vs EONR Comparison
TSBX vs EONR Comparison
Compare TSBX & EONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSBX
- EONR
- Stock Information
- Founded
- TSBX 2015
- EONR 2020
- Country
- TSBX United States
- EONR United States
- Employees
- TSBX N/A
- EONR N/A
- Industry
- TSBX
- EONR
- Sector
- TSBX
- EONR
- Exchange
- TSBX Nasdaq
- EONR NYSE
- Market Cap
- TSBX 11.4M
- EONR 10.7M
- IPO Year
- TSBX 2023
- EONR N/A
- Fundamental
- Price
- TSBX $0.48
- EONR $0.59
- Analyst Decision
- TSBX Buy
- EONR Strong Buy
- Analyst Count
- TSBX 3
- EONR 1
- Target Price
- TSBX $4.75
- EONR $4.50
- AVG Volume (30 Days)
- TSBX 93.1K
- EONR 144.3K
- Earning Date
- TSBX 11-12-2024
- EONR 02-15-2025
- Dividend Yield
- TSBX N/A
- EONR N/A
- EPS Growth
- TSBX N/A
- EONR N/A
- EPS
- TSBX N/A
- EONR N/A
- Revenue
- TSBX N/A
- EONR $21,714,016.00
- Revenue This Year
- TSBX N/A
- EONR N/A
- Revenue Next Year
- TSBX N/A
- EONR N/A
- P/E Ratio
- TSBX N/A
- EONR N/A
- Revenue Growth
- TSBX N/A
- EONR N/A
- 52 Week Low
- TSBX $0.40
- EONR $0.51
- 52 Week High
- TSBX $5.75
- EONR $6.00
- Technical
- Relative Strength Index (RSI)
- TSBX 39.58
- EONR N/A
- Support Level
- TSBX $0.48
- EONR N/A
- Resistance Level
- TSBX $0.51
- EONR N/A
- Average True Range (ATR)
- TSBX 0.05
- EONR 0.00
- MACD
- TSBX -0.00
- EONR 0.00
- Stochastic Oscillator
- TSBX 22.22
- EONR 0.00
About TSBX Turnstone Biologics Corp.
Turnstone Biologics Corp is a clinical-stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors. The company is pioneering a differentiated approach to tumor-infiltrating lymphocytes, or TILs, a clinically validated technology for treating solid tumors. It is developing next-generation TIL therapies by selecting the most potent and tumor-reactive T cells, which are referred to as Selected TILs. TILs are a type of cell therapy that harnesses the patient's own immune cells to target their own tumors. TIL therapy involves the isolation of lymphocytes from the patient's tumor, expansion of the isolated cells outside the body, and then infusion of the cells back into the patient.
About EONR EON RESOURCES INC
EON Resources Inc is an independent upstream energy company focused on maximizing total returns to its shareholders through the development of onshore oil and natural gas properties in the United States. Its current focus is as an upstream energy company producing oil and gas properties in the Permian Basin.